EUVIMEDOdkrijte EUVIMED
Open access · CC BY-NC-ND 4.0

Is there an increased risk of genetic abnormalities in fetuses with congenital heart disease in the setting of growth restriction?

Kathleen Gianforcaro, Lisa Pilchman, Laura Conway, Julie S Moldenhauer, Jack Rychik, Shelly Soni iD

Prenatal Diagnosis · 2024

DOI: 10.1002/pd.6597 ↗

At a glance

Journal article in Prenatal Diagnosis, 2024. Written by Kathleen Gianforcaro and 5 co-authors. Institution: Richard D. Wood Jr Center for Fetal Diagnosis & Treatment, Department of General, Thoracic & Fetal Surgery, Children's Hospital of Philadelphia, Phil…. Major MEDLINE topics: Fetal Growth Retardation, Heart Defects, Congenital. Cited 2 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

PovzetekSubjectsBibliografski podatkiCiteRelated studies

Abstract (original language)

Objective

To determine if the presence of fetal growth restriction (FGR) is associated with an increased risk of genetic abnormalities in the setting of congenital heart disease (CHD).

Methods

This was a retrospective cohort study involving pregnancies that met the following criteria: (i) prenatal diagnosis of CHD, (ii) singleton live‐birth, and (iii) genetic testing was performed either pre‐ or postnatally. Genetic results were reviewed by a clinical geneticist for updated variant classification. Fetal growth was stratified as appropriate for gestational age (AGA) or FGR.

Results

Of the total of 445 fetuses that met the study criteria, 325 (73.0%) were AGA and 120 (27.0%) were FGR. Genetic abnormalities were detected in 131 (29.4%) pregnancies. There was a higher rate of genetic abnormalities (36.7% vs. 26.8%, p = 0.04), which was driven by aneuploidies (20.8% vs. 8.9%, p = 0.0006) in the FGR population. Early onset growth restriction was associated with a higher rate of genetic abnormalities (44.5% vs. 25.9%, p = 0.03). The rate of genetic abnormalities was significantly higher in the shunt category as compared to remainder of the cardiac anomalies (62.5% in shunt lesions vs. 24.7%, p < 0.00001). The rates of FGR (40.9% vs. 21.4%, p < 0.0001) and genetic abnormalities (52% vs. 20.4%, p < 0.0001) were significantly higher in the presence of extra‐cardiac anomalies (ECA).

Conclusion

The presence of FGR in fetal CHD population was associated with underlying genetic abnormalities, specifically aneuploidies. Patients should be appropriately counseled regarding the higher likelihood of a genetic condition in the presence of FGR, early onset FGR, shunt lesions and ECA.

Subjects

MeSH terms (MEDLINE)

Fetal Growth RetardationHeart Defects, CongenitalHumansFemalePregnancyRetrospective StudiesAdultCohort StudiesGenetic TestingPrenatal Diagnosis

Authors and institutions

  • Richard D. Wood Jr Center for Fetal Diagnosis & Treatment, Department of General, Thoracic & Fetal Surgery, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Cardiology, The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

ORCID profiles: Shelly Soni

Cite

APA

Gianforcaro, K., Pilchman, L., Conway, L., Moldenhauer, J. S., Rychik, J., & Soni, S. (2024). Is there an increased risk of genetic abnormalities in fetuses with congenital heart disease in the setting of growth restriction?. Prenatal Diagnosis. https://doi.org/10.1002/pd.6597

Vancouver

Gianforcaro K, Pilchman L, Conway L, Moldenhauer JS, Rychik J, Soni S. Is there an increased risk of genetic abnormalities in fetuses with congenital heart disease in the setting of growth restriction?. Prenatal Diagnosis. 2024. doi:10.1002/pd.6597

BibTeX
@article{Gianforcaro2024,
  author = {Gianforcaro, Kathleen and Pilchman, Lisa and Conway, Laura and Moldenhauer, Julie S and Rychik, Jack and Soni, Shelly},
  title = {Is there an increased risk of genetic abnormalities in fetuses with congenital heart disease in the setting of growth restriction?},
  journal = {Prenatal Diagnosis},
  year = {2024},
  doi = {10.1002/pd.6597}
}
Start for free →